Edit Entry

Marc S. Ernstoff, M.D.

Title(s):
Professor of Medicine

Department(s):
Medicine

Education:
Emory University, BA 1974
New York University School of Medicine, MD 1978

Curriculum Vitae:
Ernstoff_M_CV_2009-02-02.pdf

NIH Biosketch:
Ernstoff_M_BIO_2009-02-02.pdf

Contact Information:

Dartmouth Medical School
HB 7999
Hanover NH 03755


Selected Publications:

 

Lines JL, Pantazi E, Mak J, Sempere LF, Wang L, O'Connell S, Ceeraz S, Suriawinata AA, Yan S, Ernstoff MS, Noelle R
VISTA Is an Immune Checkpoint Molecule for Human T Cells.
Cancer Res 2014 Apr 1; 74(7):1924-32
PMID: 24691993

Jenkins MH, Steinberg SM, Alexander MP, Fisher JL, Ernstoff MS, Turk MJ, Mullins DW, Brinckerhoff CE
Multiple murine BRaf(V600E) melanoma cell lines with sensitivity to PLX4032.
Pigment Cell Melanoma Res 2014 May; 27(3):495-501
PMID: 24460976

Talebian L, Fischer DA, Wu J, Channon JY, Sentman CL, Ernstoff MS, Meehan KR
The natural killer-activating receptor, NKG2D, on CD3+CD8+ T cells plays a critical role in identifying and killing autologous myeloma cells.
Transfusion 2014 Jan 22;
PMID: 24446786

Swartz HM, Williams BB, Zaki BI, Hartford AC, Jarvis LA, Chen EY, Comi RJ, Ernstoff MS, Hou H, Khan N, Swarts SG, Flood AB, Kuppusamy P
Clinical EPR: unique opportunities and some challenges.
Acad Radiol 2014 Feb; 21(2):197-206
PMID: 24439333

Dandamudi UB, Ghebremichael M, Sosman JA, Clark JI, McDermott DF, Atkins MB, Dutcher JP, Urba WJ, Regan MM, Puzanov I, Crocenzi TS, Curti BD, Vaishampayan UN, Crosby NA, Margolin KA, Ernstoff MS
A phase II study of bevacizumab and high-dose interleukin-2 in patients with metastatic renal cell carcinoma: a Cytokine Working Group (CWG) study.
J Immunother 2013 Nov-Dec; 36(9):490-5
PMID: 24145360

Hourdequin KC, Lefferts JA, Brennick JB, Ernstoff MS, Tsongalis GJ, Pipas JM
Merkel cell polyomavirus and extrapulmonary small cell carcinoma.
Oncol Lett 2013 Oct; 6(4):1049-1052
PMID: 24137462

Wrzesinski SH, Fisher JL, Ernstoff MS
Genetic profiles of plasmacytoid (BDCA-4 expressing) DC subtypes-clues to DC subtype function in vivo.
Exp Hematol Oncol 2013 Mar 9; 2(1):8
PMID: 23497451

Wolf B, Schwarzer A, Cote AL, Hampton TH, Schwaab T, Huarte E, Tomlinson CR, Gui J, Fisher JL, Fadul CE, Hamilton JW, Ernstoff MS
Gene expression profile of peripheral blood lymphocytes from renal cell carcinoma patients treated with IL-2, interferon-α and dendritic cell vaccine.
PLoS One 2012; 7(12):e50221
PMID: 23226513

Schwarzer A, Wolf B, Fisher JL, Schwaab T, Olek S, Baron U, Tomlinson CR, Seigne JD, Crosby NA, Gui J, Hampton TH, Fadul CE, Heaney JA, Ernstoff MS
Regulatory T-cells and associated pathways in metastatic renal cell carcinoma (mRCC) patients undergoing DC-vaccination and cytokine-therapy.
PLoS One 2012; 7(10):e46600
PMID: 23118856

Meehan KR, Talebian L, Tosteson TD, Hill JM, Szczepiorkowski Z, Sentman CL, Ernstoff MS
Adoptive cellular therapy using cells enriched for NKG2D+CD3+CD8+T cells after autologous transplantation for myeloma.
Biol Blood Marrow Transplant 2013 Jan; 19(1):129-37
PMID: 22975165